High
0.990
Open
0.964
VWAP
0.96
Vol
23.30K
Mkt Cap
74.46M
Low
0.950
Amount
22.48K
EV/EBITDA(TTM)
--
Total Shares
77.23M
EV
72.95M
EV/OCF(TTM)
--
P/S(TTM)
8.96
Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
2.50M
+11.17%
--
--
2.60M
+40.26%
--
--
2.30M
-8.51%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Milestone Scientific Inc. (MLSS) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -25.78%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-25.78%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Milestone Scientific Inc (MLSS.A) is -24.29, compared to its 5-year average forward P/E of -16.16. For a more detailed relative valuation and DCF analysis to assess Milestone Scientific Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-16.16
Current PE
-24.29
Overvalued PE
-9.66
Undervalued PE
-22.67
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
9.31
Current PS
7.12
Overvalued PS
14.47
Undervalued PS
4.14
Financials
Annual
Quarterly
FY2024Q4
YoY :
-10.93%
2.01M
Total Revenue
FY2024Q4
YoY :
+3.17%
-2.04M
Operating Profit
FY2024Q4
YoY :
+4.03%
-2.04M
Net Income after Tax
FY2024Q4
YoY :
-0.00%
-0.03
EPS - Diluted
FY2024Q4
YoY :
+21.25%
-1.52M
Free Cash Flow
FY2024Q4
YoY :
+12.57%
74.61
Gross Profit Margin - %
FY2024Q4
YoY :
-37.42%
-33.95
FCF Margin - %
FY2024Q4
YoY :
+16.79%
-101.09
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
15.5K
USD
1
6-9
Months
238.3K
USD
5
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
15.5K
USD
1
6-9
Months
238.3K
USD
5
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
MLSS News & Events
Events Timeline
2025-04-01 (ET)
2025-04-01
08:33:36
Milestone Scientific expands CompuFlo Epidural System footprint with InfiniSurg
2025-01-23 (ET)
2025-01-23
10:05:55
Milestone Scientific announces CompuFlo rollout at Advanced Spine and Pain
2024-11-26 (ET)
2024-11-26
07:36:21
Milestone Scientific announces approval on contract for FSS
Sign Up For More Events
Sign Up For More Events
News
9.5
04-15SeekingAlphaMilestone Scientific GAAP EPS of -$0.06 misses by $0.01, revenue of $8.63M misses by $0.63M
7.5
04-01NewsfilterMilestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
5.0
02-04Business InsiderMilestone Scientific announces CompuFlo rollout at Pain Doctors Medical
Sign Up For More News
People Also Watch
EVLV
Evolv Technologies Holdings Inc
4.100
USD
-1.44%
BCAL
Southern California Bancorp
14.070
USD
+1.88%
GAIN
Gladstone Investment Corp
13.900
USD
-0.36%
PROK
ProKidney Corp
1.080
USD
+4.85%
AGS
PlayAGS Inc
12.110
USD
0.00%
GHM
Graham Corp
30.480
USD
-1.30%
ALRS
Alerus Financial Corp
20.120
USD
+13.29%
ALT
Altimmune Inc
5.100
USD
+0.79%
PFIS
Peoples Financial Services Corp
43.710
USD
+1.44%
ATRO
Astronics Corp
22.640
USD
+2.68%
FAQ
What is Milestone Scientific Inc (MLSS) stock price today?
The current price of MLSS is 0.95 USD — it has decreased -2.16 % in the last trading day.
What is Milestone Scientific Inc (MLSS)'s business?
What is the price predicton of MLSS Stock?
What is Milestone Scientific Inc (MLSS)'s revenue for the last quarter?
What is Milestone Scientific Inc (MLSS)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Milestone Scientific Inc (MLSS)'s fundamentals?
How many employees does Milestone Scientific Inc (MLSS). have?